Cargando…

FYN/TOPK/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer

BACKGROUND: FYN is a nonreceptor tyrosine kinase that regulates diverse pathological processes. The pro-cancer role of FYN in multiple malignancies has been elucidated. However, the mechanisms that FYN promotes gastric cancer (GC) progression remain largely unknown. METHODS: In vitro and in vivo ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, SanFei, Yin, YuHan, Zhang, YiZheng, Zhu, Feng, Yang, Ge, Fu, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071617/ https://www.ncbi.nlm.nih.gov/pubmed/37016377 http://dx.doi.org/10.1186/s13046-023-02652-x

Ejemplares similares

FYN: emerging biological roles and potential therapeutic targets in cancer
por: Peng, SanFei, et al.
Publicado: (2023)

PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
por: Dou, Xiaoyan, et al.
Publicado: (2015)

Competing endogenous RNA network analysis reveals potential long non-coding RNAs as predictive biomarkers of gastric cancer
por: Peng, Sanfei, et al.
Publicado: (2020)

Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells
por: Xiao, Juanjuan, et al.
Publicado: (2019)

Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon
por: Xiao, Juanjuan, et al.
Publicado: (2016)

TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer
por: Sun, Huimin, et al.
Publicado: (2015)

FYN promotes gastric cancer metastasis by activating STAT3-mediated epithelial-mesenchymal transition
por: Yu, Jie, et al.
Publicado: (2020)

HSPB1 Facilitates the Formation of Non-Centrosomal Microtubules
por: Almeida-Souza, Leonardo, et al.
Publicado: (2013)

Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis
por: Zhang, Enxiang, et al.
Publicado: (2018)

HSPB1, HSPB6, HSPB7 and HSPB8 Protect against RhoA GTPase-Induced Remodeling in Tachypaced Atrial Myocytes
por: Ke, Lei, et al.
Publicado: (2011)

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
por: Ohashi, Takuma, et al.
Publicado: (2017)

PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas
por: Zhu, Kejing, et al.
Publicado: (2022)

Human HspB1, HspB3, HspB5 and HspB8: Shaping these disease factors during vertebrate evolution
por: Benndorf, Rainer, et al.
Publicado: (2022)

Fyn regeneration
por: Short, Ben
Publicado: (2012)

TOPK and PTEN participate in CHFR mediated mitotic checkpoint()
por: Shinde, Swapnil R., et al.
Publicado: (2013)

PBK/TOPK Expression Predicts Prognosis in Oral Cancer
por: Chang, Chin-Fang, et al.
Publicado: (2016)

Targeting PRPK and TOPK for skin cancer prevention and therapy
por: Roh, Eunmiri, et al.
Publicado: (2018)

PBK/TOPK: A Therapeutic Target Worthy of Attention
por: Han, Ziping, et al.
Publicado: (2021)

Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032
por: Eedara, Basanth Babu, et al.
Publicado: (2023)

The Role of the Arginine in the Conserved N-Terminal Domain RLFDQxFG Motif of Human Small Heat Shock Proteins HspB1, HspB4, HspB5, HspB6, and HspB8
por: Shatov, Vladislav M., et al.
Publicado: (2018)

The Fyn–ADAP Axis: Cytotoxicity Versus Cytokine Production in Killer Cells
por: Gerbec, Zachary J., et al.
Publicado: (2015)

Role of Fyn and the interleukin-6-STAT-3-autophagy axis in sarcopenia
por: Sasaki, Tsuyoshi, et al.
Publicado: (2023)

Expression and Activity of Fyn Mediate Proliferation and Blastic Features of Chronic Myelogenous Leukemia
por: Singh, Melissa M., et al.
Publicado: (2012)

HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins
por: Arrigo, André-Patrick, et al.
Publicado: (2014)

PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential
por: Huang, Hai, et al.
Publicado: (2021)

SNP rs12982687 affects binding capacity of lncRNA UCA1 with miR-873-5p: involvement in smoking-triggered colorectal cancer progression
por: Fu, Yang, et al.
Publicado: (2020)

TOPK inhibits autophagy by phosphorylating ULK1 and promotes glioma resistance to TMZ
por: Lu, Hui, et al.
Publicado: (2019)

Small nucleolar RNA host gene 1 promotes development and progression of colorectal cancer through negative regulation of miR‐137
por: Fu, Yang, et al.
Publicado: (2019)

Characterization of Hspb8 in Zebrafish
por: Dubińska-Magiera, Magda, et al.
Publicado: (2020)

HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer
por: Liang, Yiran, et al.
Publicado: (2023)

OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance
por: Yang, Yuqi, et al.
Publicado: (2021)

TOPK mediates immune evasion of renal cell carcinoma via upregulating the expression of PD-L1
por: Li, Jinxin, et al.
Publicado: (2023)

Dasatinib reduces 5-Fu-triggered apoptosis in colon carcinoma by directly modulating Src-dependent caspase-9 phosphorylation
por: Fu, Yang, et al.
Publicado: (2018)

Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion
por: Seol, Min-Ah, et al.
Publicado: (2017)

FYN is required for ARHGEF16 to promote proliferation and migration in colon cancer cells
por: Yu, Bei, et al.
Publicado: (2020)

circRNA_0005529 facilitates growth and metastasis of gastric cancer via regulating miR-527/Sp1 axis
por: Zhang, Xing, et al.
Publicado: (2021)

Terminal Regions Confer Plasticity to the Tetrameric Assembly of Human HspB2 and HspB3
por: Clark, Alice R., et al.
Publicado: (2018)

HSPB1 Enhances SIRT2-Mediated G6PD Activation and Promotes Glioma Cell Proliferation
por: Ye, Hongxing, et al.
Publicado: (2016)

TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1/eEF1A1 signal pathway
por: Wu, Wenjie, et al.
Publicado: (2023)

MiR‐363‐5p modulates regulatory T cells through STAT4‐HSPB1‐Notch1 axis and is associated with the immunological abnormality in Graves' disease
por: Yin, Xianlun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_chgr4fu4rjldo25pdlml4ajm9r